H.R. 5197
119th Congress
Protect Beneficiaries from Middlemen Act
0
Cosponsors
4
Actions
0
Amendments
0
Committees
—
Since introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
8 September 2025·10 months ago
Summary
Introduced in House · Updated 2 December 2025
Protect Beneficiaries from Middlemen Act
This bill limits cost-sharing for covered drugs under the Medicare prescription drug benefit and Medicare Advantage.
Specifically, for costs above the deductible but below the annual out-of-pocket threshold, the bill limits cost-sharing to the average net price of the drug (i.e., the average amount paid less any rebates) or the cash price (i.e., the price charged to an individual without insurance), whichever is lower.
The Government Accountability Office must report on the bill's implementation.
Timeline
4 actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
8 September 2025 · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
8 September 2025 · IntroReferral
Introduced in House
8 September 2025 · IntroReferral
Introduced in House
8 September 2025 · IntroReferral
Sponsorship
0 cosponsors
Sponsor
Republican:Rep. Malliotakis, Nicole [R-NY-11]NYClassification
Policy area
HealthTrack Protect Beneficiaries from Middlemen Act as it moves through Congress
Get alerts on votes, amendments, and stock-market impact